🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)
China flag China · Delayed Price · Currency is CNY
16.10
-0.97 (-5.68%)
At close: Nov 20, 2026

SHE:301263 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
8,06712,2786,3486,9487,683-
Market Cap Growth
-35.82%93.40%-8.63%-9.56%--
Enterprise Value
8,16012,1216,0666,2716,685-
Last Close Price
16.1024.1112.3713.2114.33-

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
PE Ratio
275.95428.8058.6643.3744.00-
Forward PE
-66.8325.8522.5228.32-
PS Ratio
11.8318.198.819.139.81-
PB Ratio
5.407.053.503.804.14-
P/TBV Ratio
9.089.714.564.864.36-
P/FCF Ratio
--305.50-130.35-
P/OCF Ratio
65.06-71.0774.2951.63-

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
EV/Sales Ratio
11.9717.968.418.248.53-
EV/EBITDA Ratio
123.06174.1637.2428.3729.48-
EV/EBIT Ratio
-2075.3955.1234.1434.32-
EV/FCF Ratio
--291.92-113.43-

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Debt / Equity Ratio
0.390.210.130.100.010.15
Debt / EBITDA Ratio
9.095.081.480.790.100.70
Debt / FCF Ratio
--11.68-0.391.45
Net Debt / Equity Ratio
0.02-0.15-0.23-0.29-0.55-0.04
Net Debt / EBITDA Ratio
0.47-3.71-2.59-2.40-4.52-0.18
Net Debt / FCF Ratio
-1.932.13-20.284.99-17.38-0.38
Asset Turnover
0.270.280.320.360.530.74
Inventory Turnover
2.483.123.333.644.183.70
Quick Ratio
1.251.982.684.219.152.23
Current Ratio
1.462.263.054.699.812.66
Return on Equity (ROE)
0.64%0.72%5.32%8.33%13.62%18.47%
Return on Assets (ROA)
-0.18%0.15%3.03%5.38%8.17%8.98%
Return on Invested Capital (ROIC)
-0.47%0.41%7.51%13.78%21.71%17.07%
Return on Capital Employed (ROCE)
-0.40%0.30%5.70%9.30%10.30%17.30%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Jan '25 Jan '24 Jan '23 Jan '22
Earnings Yield
0.36%0.23%1.70%2.31%2.27%-
FCF Yield
-0.19%-0.99%0.33%-1.53%0.77%-
Dividend Yield
0.26%0.17%1.33%1.83%2.15%-
Payout Ratio
110.72%326.83%124.86%104.11%49.14%3.56%
Buyback Yield / Dilution
2.39%1.66%1.27%-6.23%-24.85%-6.51%
Total Shareholder Return
2.65%1.83%2.61%-4.40%-22.70%-6.51%